Shen CI - Search Results

1

Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis.

Chiang CL, Ho HL, Yeh YC, Lee CC, Huang HC, Shen CI, Luo YH, Chen YM, Chiu CH, Chou TY. Chiang CL, et al. Among authors: shen ci. J Cancer Res Clin Oncol. 2023 Jan;149(1):5-14. doi: 10.1007/s00432-022-04396-1. Epub 2022 Nov 1. J Cancer Res Clin Oncol. 2023. PMID: 36318332

2

Impending myxedema coma as the initial presentation of lung cancer.

Shen CI, Huang HC, Yeh YC, Chiu CH. Shen CI, et al. J Formos Med Assoc. 2017 Jun;116(6):488-489. doi: 10.1016/j.jfma.2016.09.009. Epub 2016 Nov 4. J Formos Med Assoc. 2017. PMID: 27823924 Free article. No abstract available.

3

Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy.

Shen CI, Huang HC, Chiang CL, Luo YH, Shiao TH, Chiu CH. Shen CI, et al. Lung Cancer. 2019 Dec;138:52-57. doi: 10.1016/j.lungcan.2019.10.001. Epub 2019 Oct 11. Lung Cancer. 2019. PMID: 31634655

4

Epidermal growth factor receptor mutations in non-small cell lung cancer undetected by high-sensitivity allele-specific real-time polymerase chain reaction-based assays.

Shen CI, Ho HL, Yeh YC, Chiu CH, Chou TY. Shen CI, et al. J Chin Med Assoc. 2020 Apr;83(4):345-349. doi: 10.1097/JCMA.0000000000000277. J Chin Med Assoc. 2020. PMID: 32101894

5

Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI.

Chiang CL, Huang HC, Shen CI, Luo YH, Chen YM, Chiu CH. Chiang CL, et al. Among authors: shen ci. Target Oncol. 2020 Aug;15(4):503-512. doi: 10.1007/s11523-020-00737-7. Target Oncol. 2020. PMID: 32696212

6

Severe hepatitis related to immune-checkpoint inhibitor in a patient with non-small-cell lung cancer and pulmonary tuberculosis.

Sun CY, Shen CI, Feng JY, Chiang CL. Sun CY, et al. Among authors: shen ci. Postgrad Med J. 2021 Sep;97(1151):556-557. doi: 10.1136/postgradmedj-2020-138123. Epub 2020 Aug 20. Postgrad Med J. 2021. PMID: 32820090 No abstract available.

7

Pneumatosis intestinalis induced by targeted therapy.

Chang CJ, Shen CI, Wu CL, Chiu CH. Chang CJ, et al. Among authors: shen ci. Postgrad Med J. 2022 Jan;98(1155):10. doi: 10.1136/postgradmedj-2020-139232. Epub 2020 Nov 24. Postgrad Med J. 2022. PMID: 33234706 No abstract available.

8

Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis.

Chiang CL, Lee CC, Huang HC, Wu CH, Yeh YC, Shen CI, Luo YH, Shiao TH, Chang HJ, Huang YT, Chen YM, Chou TY, Chiu CH. Chiang CL, et al. Among authors: shen ci. Target Oncol. 2021 Mar;16(2):207-214. doi: 10.1007/s11523-021-00791-9. Epub 2021 Feb 10. Target Oncol. 2021. PMID: 33566300

9

Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer.

Shen CI, Chao HS, Shiao TH, Chiang CL, Huang HC, Luo YH, Chiu CH, Chen YM. Shen CI, et al. Sci Rep. 2021 Aug 9;11(1):16122. doi: 10.1038/s41598-021-95628-w. Sci Rep. 2021. PMID: 34373555 Free PMC article.

10

Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report.

Shen CI, Yeh YC, Chiu CH. Shen CI, et al. JTO Clin Res Rep. 2021 Feb 17;2(5):100156. doi: 10.1016/j.jtocrr.2021.100156. eCollection 2021 May. JTO Clin Res Rep. 2021. PMID: 34590016 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page